3. Cortes GA, Moore M, El-Nakeep S. Physiology, Von Willebrand Factor. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK559062/
4. Swami A and Kaur V. von Willebrand disease: a concise review and update for the practicing physician. Hemostasis. 2017;23(7):900-10.
5. National Heart Lung and Blood Institute. The diagnosis, evaluation, and management of von Willebrand disease. National Heart Lung and Blood Institute, 2007. https://www.nhlbi.nih.gov/sites/default/files/media/docs/vwd.pdf.
6. James P. (2022). Pathophysiology of von Willebrand Disease. https://www.uptodate.com/contents/pathophysiology-of-von-willebrand-disease
7. Sabih A and Babiker H. von Willebrand disease. Statpearls, 2021. https://www.statpearls.com/ArticleLibrary/viewarticle/31270.
9. Pollack ES, Nagalla S, Conrad ME, Krishnan K, Stein S, Telavera F. von Willebrand disease clinical presentation. Medscape, 2021. https://emedicine.medscape.com/article/206996-clinical#b1.
10. Odom B, Khourdaji I, Golas V, Zekman R, Rosenberg B. Acquired von Willebrand disease secondary to clear cell renal cell carcinoma. J Endourol Case Rep. 2018;4:114-5. http://online.liebertpub.com/doi/10.1089/cren.2018.0032.
11. Massimo Franchini, Pier Mannuccio Mannucci. Acquired von Willebrand syndrome: focused for hematologists. Haematologica 2020;105(8):2032-2037; https://doi.org/10.3324/haematol.2020.255117.
22. Bragadottir G, Birgisdottir ER, Gudmundsdottir BR, Hilmarsdottir B, Vidarsson B, Magnusson MK, Larsen OH, Sorensen B, Ingerslev J, Onundarson PT. Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome- a case control study. Am J Hematol. 2015;90(2):149-55. doi: 10.1002/ajh.23891.
43. Rick EM. (2021). von Willebrand disease (VWD): Treatment of major bleeding and major surgery. https://www.uptodate.com/contents/von-willebrand-disease-vwd-treatment-of-major-bleeding-and-major-surgery